Physician profile
Denis Nunez Sanchez
NPI 1235534546
$992.08
in general payments reported to CMS, 2019-2025
14 companies · $20.56 in 2025
The $20.56 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $135 · 2023: $250 · 2024: $310 · 2025: $20.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $244.46 | 2022-2024 | |
| Lilly USA, LLC | $199.50 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $133.11 | 2022-2025 | |
| Abbvie INC. | $105.32 | 2021-2023 | |
| Novo Nordisk INC | $67.98 | 2023-2024 | Ozempic, Rybelsus |
| Inspire Medical Systems, INC. | $44.06 | 2024 | Inspire |
| Genentech USA, INC. | $34.80 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.92 | 2021 | |
| Exact Sciences Corporation | $27.87 | 2023 | Cologuard Collection Kit |
| Alnylam Pharmaceuticals INC. | $22.00 | 2022 | |
| Amarin Pharma, INC. | $21.81 | 2021 | |
| Dexcom, INC. | $21.43 | 2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $19.34 | 2021 | |
| Amgen INC. | $16.48 | 2023 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denis Nunez Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.